Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
51,925,328
-
Share change
-
-892,642
-
Total reported value
-
$421,213,170
-
Price per share
-
$8.14
-
Number of holders
-
75
-
Value change
-
-$8,474,813
-
Number of buys
-
46
-
Number of sells
-
19
Institutional Holders of TRANSLATE BIO INC - COM (TBIO) as of Q4 2019
As of 31 Dec 2019,
TRANSLATE BIO INC - COM (TBIO) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,925,328 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, FMR LLC, Atlas Venture Advisors, Inc., RTW INVESTMENTS, LP, BlackRock Inc., Omega Fund Management, LLC, FRAZIER MANAGEMENT LLC, FEDERATED HERMES, INC., VANGUARD GROUP INC, and Camber Capital Management LP.
This page lists
75
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.